All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Genomic Health, Inc. revenue reports

Genomic Health, Inc. financial reports, Genomic Health, Inc. annual revenue in 2024. When does Genomic Health, Inc. report revenue?
Add to widgets
Added to widgets

Genomic Health, Inc. total revenue, net income and dynamics of changes in US dollar today

Genomic Health, Inc. current income in US dollar. Genomic Health, Inc. net income is now 12 999 000 $. Net income, revenue and dynamics - the main financial indicators of Genomic Health, Inc.. The financial report chart on our website displays information by dates from 30/06/2017 to 31/03/2019. The value of "net income" Genomic Health, Inc. on the graph is displayed in blue. The value of the "total revenue of Genomic Health, Inc." on the chart is marked in yellow.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2019 108 769 000 $ +17.43 % ↑ 12 999 000 $ -
31/12/2018 104 609 000 $ +19.6 % ↑ 8 910 000 $ +374.19 % ↑
30/09/2018 101 258 000 $ +20.8 % ↑ 12 225 000 $ -
30/06/2018 95 619 000 $ +11.85 % ↑ 8 317 000 $ -
31/03/2018 92 625 000 $ - -3 775 000 $ -
31/12/2017 87 463 000 $ - 1 879 000 $ -
30/09/2017 83 821 000 $ - -2 191 000 $ -
30/06/2017 85 487 000 $ - -2 739 000 $ -
Show:
to

Genomic Health, Inc. financial report charts

The latest dates of Genomic Health, Inc. financial statements available online: 30/06/2017, 31/12/2018, 31/03/2019. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Genomic Health, Inc. for today is 31/03/2019. Gross profit Genomic Health, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Genomic Health, Inc. is 76 707 000 $

Genomic Health, Inc. quarterly report dates

Cost of revenue Genomic Health, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Genomic Health, Inc. is 32 062 000 $ Total revenue Genomic Health, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Genomic Health, Inc. is 108 769 000 $ Operating revenue Genomic Health, Inc. is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Genomic Health, Inc. is 108 769 000 $

Operating income Genomic Health, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Genomic Health, Inc. is 11 539 000 $ Net income Genomic Health, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Genomic Health, Inc. is 12 999 000 $ Current assets Genomic Health, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Genomic Health, Inc. is 280 651 000 $

31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
76 707 000 $ 30 206 000 $ 83 400 000 $ 78 407 000 $ 73 892 000 $ 73 649 000 $ 70 388 000 $ 71 689 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
32 062 000 $ 74 403 000 $ 17 858 000 $ 17 212 000 $ 18 733 000 $ 13 814 000 $ 13 433 000 $ 13 798 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
108 769 000 $ 104 609 000 $ 101 258 000 $ 95 619 000 $ 92 625 000 $ 87 463 000 $ 83 821 000 $ 85 487 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
108 769 000 $ 104 609 000 $ 101 258 000 $ 95 619 000 $ 92 625 000 $ 87 463 000 $ 83 821 000 $ 85 487 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
11 539 000 $ 6 917 000 $ 11 758 000 $ 7 100 000 $ -4 388 000 $ 2 150 000 $ -2 632 000 $ -3 143 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
12 999 000 $ 8 910 000 $ 12 225 000 $ 8 317 000 $ -3 775 000 $ 1 879 000 $ -2 191 000 $ -2 739 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- -38 964 000 $ 13 093 000 $ 12 483 000 $ 16 807 000 $ 14 943 000 $ 17 212 000 $ 15 781 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
97 230 000 $ 97 692 000 $ 89 500 000 $ 88 519 000 $ 78 280 000 $ 71 499 000 $ 73 020 000 $ 74 832 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
280 651 000 $ 274 836 000 $ 246 702 000 $ 215 376 000 $ 190 989 000 $ 174 260 000 $ 166 051 000 $ 154 504 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
392 790 000 $ 334 372 000 $ 300 366 000 $ 269 016 000 $ 242 939 000 $ 231 617 000 $ 222 984 000 $ 212 930 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
101 406 000 $ 61 645 000 $ 69 242 000 $ 53 847 000 $ 42 279 000 $ 45 518 000 $ 43 019 000 $ 42 200 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
49 486 000 $ 59 776 000 $ 50 405 000 $ 39 987 000 $ - - - -
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - 130 387 000 $ 129 575 000 $ 118 961 000 $ 109 799 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
104 909 000 $ 64 212 000 $ 54 349 000 $ 43 813 000 $ - - - -
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
26.71 % 19.20 % 18.09 % 16.29 % - - - -
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
287 881 000 $ 270 160 000 $ 246 017 000 $ 225 203 000 $ 200 392 000 $ 188 291 000 $ 174 695 000 $ 169 947 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-3 669 000 $ 24 576 000 $ 29 745 000 $ 15 961 000 $ 6 280 000 $ 9 135 000 $ 9 572 000 $ 11 116 000 $

Last revenue report of Genomic Health, Inc. was 31/03/2019. According to last financial report total revenue in Genomic Health, Inc. was 108 769 000 US dollar and changed by +17.43% since last year. Net income in Genomic Health, Inc. was 12 999 000 $ in last quartal, net income changes to +374.19%.

Total assets Genomic Health, Inc. refers to the total amount of assets owned by a person or entity. Total assets Genomic Health, Inc. is 392 790 000 $ Current cash Genomic Health, Inc. - the sum of all of the cash a company has on the date of report. Current cash Genomic Health, Inc. is 101 406 000 $ Current debt Genomic Health, Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Genomic Health, Inc. is 49 486 000 $

Genomic Health, Inc. stocks data

Genomic Health, Inc. financials